These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 18558011)

  • 21. Blood genomic profiles of exposures to Venezuelan equine encephalitis in Cynomolgus macaques (Macaca fascicularis).
    Hammamieh R; Barmada M; Ludwig G; Peel S; Koterski N; Jett M
    Virol J; 2007 Aug; 4():82. PubMed ID: 17727720
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inflammation is a component of neurodegeneration in response to Venezuelan equine encephalitis virus infection in mice.
    Schoneboom BA; Catlin KM; Marty AM; Grieder FB
    J Neuroimmunol; 2000 Sep; 109(2):132-46. PubMed ID: 10996215
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Efficacy of FDA-Approved Anti-Inflammatory Drugs Against Venezuelan Equine Encephalitis Virus Infection.
    Risner K; Ahmed A; Bakovic A; Kortchak S; Bhalla N; Narayanan A
    Viruses; 2019 Dec; 11(12):. PubMed ID: 31842327
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evaluation of neurovirulence and biodistribution of Venezuelan equine encephalitis replicon particles expressing herpes simplex virus type 2 glycoprotein D.
    Kowalski J; Adkins K; Gangolli S; Ren J; Arendt H; DeStefano J; Obregon J; Tummolo D; Natuk RJ; Brown TP; Parks CL; Udem SA; Long D
    Vaccine; 2007 Mar; 25(12):2296-305. PubMed ID: 17239997
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Role of angiotensin II in experimental Venezuelan equine encephalitis in rats.
    Bermúdez J; Valero N; Mosquera J; Vargas R; Hernández-Fonseca JP; Quiroz Y; Godoy R
    Arch Virol; 2015 Oct; 160(10):2395-405. PubMed ID: 26156105
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Entry receptor LDLRAD3 is required for Venezuelan equine encephalitis virus peripheral infection and neurotropism leading to pathogenesis in mice.
    Kafai NM; Janova H; Cain MD; Alippe Y; Muraro S; Sariol A; Elam-Noll M; Klein RS; Diamond MS
    Cell Rep; 2023 Aug; 42(8):112946. PubMed ID: 37556325
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Entry Sites of Venezuelan and Western Equine Encephalitis Viruses in the Mouse Central Nervous System following Peripheral Infection.
    Phillips AT; Rico AB; Stauft CB; Hammond SL; Aboellail TA; Tjalkens RB; Olson KE
    J Virol; 2016 Jun; 90(12):5785-96. PubMed ID: 27053560
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Small molecule inhibitors of Ago2 decrease Venezuelan equine encephalitis virus replication.
    Madsen C; Hooper I; Lundberg L; Shafagati N; Johnson A; Senina S; de la Fuente C; Hoover LI; Fredricksen BL; Dinman J; Jacobs JL; Kehn-Hall K
    Antiviral Res; 2014 Dec; 112():26-37. PubMed ID: 25448087
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Apoptotic cell death is an important cause of neuronal injury in experimental Venezuelan equine encephalitis virus infection of mice.
    Jackson AC; Rossiter JP
    Acta Neuropathol; 1997 Apr; 93(4):349-53. PubMed ID: 9113200
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Vaccinia virus recombinants encoding the truncated structural gene region of Venezuelan equine encephalitis virus (VEEV) give solid protection against peripheral challenge but only partial protection against airborne challenge with virulent VEEV.
    Phillpotts RJ; Lescott TL; Jacobs SC
    Acta Virol; 2000 Oct; 44(5):233-9. PubMed ID: 11252667
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Modification of Venezuelan equine encephalomyelitis virus infection in mice by X radiation.
    Hilmas DE; Whitmire RE; Dill GS
    Am J Vet Res; 1977 Sep; 38(9):1413-9. PubMed ID: 921037
    [TBL] [Abstract][Full Text] [Related]  

  • 32. C3H/HeN mouse model for the evaluation of antiviral agents for the treatment of Venezuelan equine encephalitis virus infection.
    Julander JG; Skirpstunas R; Siddharthan V; Shafer K; Hoopes JD; Smee DF; Morrey JD
    Antiviral Res; 2008 Jun; 78(3):230-41. PubMed ID: 18313150
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Protection of mice by equine herpesvirus type 1 based experimental vaccine against lethal Venezuelan equine encephalitis virus infection in the absence of neutralizing antibodies.
    Rosas CT; Paessler S; Ni H; Osterrieder N
    Am J Trop Med Hyg; 2008 Jan; 78(1):83-92. PubMed ID: 18187789
    [TBL] [Abstract][Full Text] [Related]  

  • 34. 1,5-Iodonaphthyl azide-inactivated V3526 protects against aerosol challenge with virulent venezuelan equine encephalitis virus.
    Gupta P; Sharma A; Spurgers KB; Bakken RR; Eccleston LT; Cohen JW; Honnold SP; Glass PJ; Maheshwari RK
    Vaccine; 2016 May; 34(25):2762-5. PubMed ID: 27129427
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Establishment of a One-Step Real-Time RT-PCR Method for the Detection of Venezuelan Equine Encephalitis Virus].
    Qian S; He B; Tu Z; Guo H; Tu C
    Bing Du Xue Bao; 2015 Mar; 31(2):107-13. PubMed ID: 26164934
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparative pathology study of Venezuelan, eastern, and western equine encephalitis viruses in non-human primates.
    Smith DR; Schmaljohn CS; Badger C; Ostrowski K; Zeng X; Grimes SD; Rayner JO
    Antiviral Res; 2020 Oct; 182():104875. PubMed ID: 32755661
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Induction of protective immune responses against Venezuelan equine encephalitis (VEE) virus aerosol challenge with microencapsulated VEE virus vaccine.
    Greenway TE; Eldridge JH; Ludwig G; Staas JK; Smith JF; Gilley RM; Michalek SM
    Vaccine; 1998 Aug; 16(13):1314-23. PubMed ID: 9682396
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Venezuelan encephalitis emergence mediated by a phylogenetically predicted viral mutation.
    Anishchenko M; Bowen RA; Paessler S; Austgen L; Greene IP; Weaver SC
    Proc Natl Acad Sci U S A; 2006 Mar; 103(13):4994-9. PubMed ID: 16549790
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparative neurovirulence and tissue tropism of wild-type and attenuated strains of Venezuelan equine encephalitis virus administered by aerosol in C3H/HeN and BALB/c mice.
    Steele KE; Davis KJ; Stephan K; Kell W; Vogel P; Hart MK
    Vet Pathol; 1998 Sep; 35(5):386-97. PubMed ID: 9754544
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Synthetic Host Defense Peptides Inhibit Venezuelan Equine Encephalitis Virus Replication and the Associated Inflammatory Response.
    Ahmed A; Bakovic A; Risner K; Kortchak S; Der Torossian Torres M; de la Fuente-Nunez C; Lu T; Bhalla N; Narayanan A
    Sci Rep; 2020 Dec; 10(1):21491. PubMed ID: 33293592
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.